'Patent working' details may fuel compulsory licensing in India
This article was originally published in Scrip
Executive Summary
India's plans to make public details on the 'working' of patented medicines in the country are expected to rekindle the debate on whether the mere importation of a patented drug constitutes 'working' of patents under Indian law. India's controller general of patents, designs and trade marks, PH Kurian, has said recently that working details provided by patentees under Form 27 would be provided on the patent office website from June.